Renal Dialysis Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Renal Dialysis Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Renal Dialysis Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Renal Dialysis Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Renal dialysis equipment is intended to provide an artificial replacement for lost kidney function due to renal failure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Renal Dialysis Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Renal Dialysis Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Renal Dialysis Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Renal Dialysis Equipment Overview
4 Products under Development
4.1 Renal Dialysis Equipment - Pipeline Products by Stage of Development
4.2 Renal Dialysis Equipment - Pipeline Products by Segment
4.3 Renal Dialysis Equipment - Pipeline Products by Territory
4.4 Renal Dialysis Equipment - Pipeline Products by Regulatory Path
4.5 Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date
4.6 Renal Dialysis Equipment - Ongoing Clinical Trials
5 Renal Dialysis Equipment - Pipeline Products under Development by Companies
5.1 Renal Dialysis Equipment Companies - Pipeline Products by Stage of Development
5.2 Renal Dialysis Equipment – Companies Pipeline Products by Stage of Development
6 Renal Dialysis Equipment Companies and Product Overview
6.1 Access Vascular Inc Company Overview
6.1.1 Access Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Acotec Scientific Holdings Ltd Company Overview
6.2.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.3 Advanced Dialysis Methods Ltd. Company Overview
6.3.1 Advanced Dialysis Methods Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6.4 Advent Access Pte Ltd Company Overview
6.4.1 Advent Access Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.5 AngioDynamics Inc Company Overview
6.5.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.6 Angiotech Pharmaceuticals Inc Company Overview
6.6.1 Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 Aperture Biomedical LLC Company Overview
6.7.1 Aperture Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview
6.8 Ariste Medical LLC Company Overview
6.8.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
6.9 Ash Access Technology Inc Company Overview
6.9.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
6.10 Baxter International Inc Company Overview
6.10.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
6.11 Biosurfaces Inc Company Overview
6.11.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
6.12 Bioteque Corp Company Overview
6.12.1 Bioteque Corp Pipeline Products & Ongoing Clinical Trials Overview
6.13 BOA Biomedical Inc Company Overview
6.13.1 BOA Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.14 Brookhaven Medical Inc Company Overview
6.14.1 Brookhaven Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.15 Byonyks Company Overview
6.15.1 Byonyks Pipeline Products & Ongoing Clinical Trials Overview
6.16 CatheNect Medical Company Overview
6.16.1 CatheNect Medical Pipeline Products & Ongoing Clinical Trials Overview
6.17 Cerovations LLC Company Overview
6.17.1 Cerovations LLC Pipeline Products & Ongoing Clinical Trials Overview
6.18 Chemica Technologies Inc Company Overview
6.18.1 Chemica Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.19 Chrysalis Medical Inc Company Overview
6.19.1 Chrysalis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.20 Columbia University Company Overview
6.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
6.21 CR Bard Inc Company Overview
6.21.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
6.22 CVS Kidney Care Company Overview
6.22.1 CVS Kidney Care Pipeline Products & Ongoing Clinical Trials Overview
6.23 Cytograft Tissue Engineering Inc (Inactive) Company Overview
6.23.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.24 Debiotech SA Company Overview
6.24.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
6.25 Dialco Medical Inc Company Overview
6.25.1 Dialco Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.26 Diality Inc Company Overview
6.26.1 Diality Inc Pipeline Products & Ongoing Clinical Trials Overview
6.27 Diavantis Company Overview
6.27.1 Diavantis Pipeline Products & Ongoing Clinical Trials Overview
6.28 Districlass Medical SA Company Overview
6.28.1 Districlass Medical SA Pipeline Products & Ongoing Clinical Trials Overview
6.29 Ellen Medical Devices Pty Ltd Company Overview
6.29.1 Ellen Medical Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.30 Emory University Company Overview
6.30.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
6.31 Eqalix, Inc. Company Overview
6.31.1 Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.32 ExThera Medical Corp Company Overview
6.32.1 ExThera Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
6.33 Fistulink Ltd. Company Overview
6.33.1 Fistulink Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6.34 Fresenius Medical Care Holdings Inc Company Overview
6.34.1 Fresenius Medical Care Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
6.35 Gambro Dasco SpA Company Overview
6.35.1 Gambro Dasco SpA Pipeline Products & Ongoing Clinical Trials Overview
6.36 Georgia Institute of Technology Company Overview
6.36.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
6.37 Glomeria Therapeutics srl Company Overview
6.37.1 Glomeria Therapeutics srl Pipeline Products & Ongoing Clinical Trials Overview
6.38 Haemair Ltd Company Overview
6.38.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.39 Healionics Corporation Company Overview
6.39.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview
6.40 Hemotek Medical Inc Company Overview
6.40.1 Hemotek Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.41 Humacyte Inc Company Overview
6.41.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
6.42 Indian Institute of Technology Bombay Company Overview
6.42.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
6.43 Infomed SA Company Overview
6.43.1 Infomed SA Pipeline Products & Ongoing Clinical Trials Overview
6.44 InnAVasc Medical Inc Company Overview
6.44.1 InnAVasc Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.45 Innovative BioTherapies Inc Company Overview
6.45.1 Innovative BioTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.46 Katharos, Inc. Company Overview
6.46.1 Katharos, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.47 Koronis Biomedical Technologies Corporation Company Overview
6.47.1 Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
6.48 Kuleana Technology Inc Company Overview
6.48.1 Kuleana Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
6.49 Laminate Medical Technologies Ltd Company Overview
6.49.1 Laminate Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.50 LiberDi Ltd Company Overview
6.50.1 LiberDi Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.51 Mar Cor Purification Inc Company Overview
6.51.1 Mar Cor Purification Inc Pipeline Products & Ongoing Clinical Trials Overview
6.52 Marvao Medical Devices Ltd Company Overview
6.52.1 Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.53 Minnesota Health Solutions Corporation Company Overview
6.53.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview
6.54 Mozarc Medical Holding LLC Company Overview
6.54.1 Mozarc Medical Holding LLC Pipeline Products & Ongoing Clinical Trials Overview
6.55 Nanodialysis BV Company Overview
6.55.1 Nanodialysis BV Pipeline Products & Ongoing Clinical Trials Overview
6.56 NanoVasc, Inc. Company Overview
6.56.1 NanoVasc, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.57 Neokidney Development BV Company Overview
6.57.1 Neokidney Development BV Pipeline Products & Ongoing Clinical Trials Overview
6.58 Nephros Inc Company Overview
6.58.1 Nephros Inc Pipeline Products & Ongoing Clinical Trials Overview
6.59 Nicast Ltd Company Overview
6.59.1 Nicast Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.60 Nikkiso Co Ltd Company Overview
6.60.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.61 Nipro Corp Company Overview
6.61.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
6.62 Northwestern University Company Overview
6.62.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
6.63 Novaflux Technologies Company Overview
6.63.1 Novaflux Technologies Pipeline Products & Ongoing Clinical Trials Overview
6.64 NuVascular Technologies Inc Company Overview
6.64.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.65 NxStage Medical Inc Company Overview
6.65.1 NxStage Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.66 Occlutech International AB Company Overview
6.66.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
6.67 Oxford Biomaterials Ltd Company Overview
6.67.1 Oxford Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.68 Padmaseetha Technologies Pvt Ltd Company Overview
6.68.1 Padmaseetha Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.69 Phase One Medical LLC Company Overview
6.69.1 Phase One Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
6.70 Phraxis, Inc. Company Overview
6.70.1 Phraxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.71 Physiologas Technologies Inc Company Overview
6.71.1 Physiologas Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.72 Qidni Labs Inc Company Overview
6.72.1 Qidni Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
6.73 Quanta Dialysis Technologies Ltd Company Overview
6.73.1 Quanta Dialysis Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.74 Rajamadhangi Medical Technologies Pvt Ltd Company Overview
6.74.1 Rajamadhangi Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.75 Rambam Health Care Campus Company Overview
6.75.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview
6.76 Redsense Medical AB Company Overview
6.76.1 Redsense Medical AB Pipeline Products & Ongoing Clinical Trials Overview
6.77 RegenMedTX LLC Company Overview
6.77.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview
6.78 Renal Solutions Inc Company Overview
6.78.1 Renal Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
6.79 SeaStar Medical Company Overview
6.79.1 SeaStar Medical Pipeline Products & Ongoing Clinical Trials Overview
6.80 Senexis Limited (Inactive) Company Overview
6.80.1 Senexis Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.81 Shandong Weigao Blood Purification Products Co Ltd Company Overview
6.81.1 Shandong Weigao Blood Purification Products Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.82 Silmag SA Company Overview
6.82.1 Silmag SA Pipeline Products & Ongoing Clinical Trials Overview
6.83 Simergent LLC Company Overview
6.83.1 Simergent LLC Pipeline Products & Ongoing Clinical Trials Overview
6.84 Southern Illinois University Carbondale Company Overview
6.84.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
6.85 Specialty Renal Products Inc Company Overview
6.85.1 Specialty Renal Products Inc Pipeline Products & Ongoing Clinical Trials Overview
6.86 Stent Tek Ltd Company Overview
6.86.1 Stent Tek Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.87 TEI Biosciences Inc Company Overview
6.87.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
6.88 Thorn Technologies LLC Company Overview
6.88.1 Thorn Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.89 Triomed AB Company Overview
6.89.1 Triomed AB Pipeline Products & Ongoing Clinical Trials Overview
6.90 University of Arizona Company Overview
6.90.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
6.91 University of California Company Overview
6.91.1 University of California Pipeline Products & Ongoing Clinical Trials Overview
6.92 University of California San Francisco Company Overview
6.92.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
6.93 University of Colorado Company Overview
6.93.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
6.94 University of Limerick Company Overview
6.94.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
6.95 University of Michigan Company Overview
6.95.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
6.96 University of Rochester Company Overview
6.96.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
6.97 University of Texas Southwestern Medical Center Company Overview
6.97.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview
6.98 University of Toledo Company Overview
6.98.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
6.99 University of Vermont Company Overview
6.99.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview
6.100 Vanderbilt University Company Overview
6.100.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
6.101 Vascoscope BV Company Overview
6.101.1 Vascoscope BV Pipeline Products & Ongoing Clinical Trials Overview
6.102 Vascudyne Inc Company Overview
6.102.1 Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
6.103 Vascular Genesis Company Overview
6.103.1 Vascular Genesis Pipeline Products & Ongoing Clinical Trials Overview
6.104 Verasonics, Inc. Company Overview
6.104.1 Verasonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.105 Vital Access Corp Company Overview
6.105.1 Vital Access Corp Pipeline Products & Ongoing Clinical Trials Overview
6.106 Vizio Medical Devices Company Overview
6.106.1 Vizio Medical Devices Pipeline Products & Ongoing Clinical Trials Overview
6.107 Voyager Biomedical Inc Company Overview
6.107.1 Voyager Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.108 Xeltis AG Company Overview
6.108.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
6.109 Xerem Medical Ltd Company Overview
6.109.1 Xerem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.110 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
6.110.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 Renal Dialysis Equipment- Recent Developments
7.1 Jun 20, 2023: Breakthrough Study Demonstrates that High-Dose Hemodiafiltration Treatment for Kidney Failure Patients Significantly Reduces Mortality Rates
7.2 Jun 09, 2023: Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
7.3 Jun 05, 2023: Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
7.4 May 15, 2023: SeaStar Medical reports Q1 2023 financial results and provides a business update
7.5 May 12, 2023: Marubun announces summary of consolidated financial results for the fiscal year ended March 31, 2023
7.6 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.7 May 10, 2023: Nephros announces results for quarter ended March 31, 2023
7.8 May 09, 2023: Redsense Medical announces interim report Q1 January - March, 2023
7.9 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook
7.10 Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023
7.11 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information
7.12 Apr 12, 2023: Medtronic has a layoff in California
7.13 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
7.14 Apr 03, 2023: Medtronic and DaVita launch new company to focus on kidney health
7.15 Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format
7.16 Mar 22, 2023: Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30
7.17 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.18 Mar 09, 2023: Somatus expands partnership with Inova to further enhance Care and Improve Outcomes for Patients
7.19 Mar 08, 2023: Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
7.20 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
7.21 Mar 08, 2023: Asahi Kasei Corp. Announces Change in Representative Directors
7.22 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
7.23 Feb 22, 2023: Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call
7.24 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
7.25 Feb 14, 2023: Marubun Notice of Revisions of Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023 and Dividend Forecast
7.26 Feb 13, 2023: Rockwell Medical and Concerto Renal Services establish new three-year, multi-million dollar product purchase agreement
7.27 Feb 10, 2023: Groundbreaking USask research identifies key blood protein target for improving dialysis
7.28 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
7.29 Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results
7.30 Feb 08, 2023: Asahi Kasei Announces Consolidated Results for 1st to 3rd Quarter Fiscal 2022
7.31 Feb 07, 2023: JMS Co Announces Financial Results for the 3rd Quarter of FYE March 2023
7.32 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
7.33 Jan 31, 2023: Marubun Corporation Announces Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2022
7.34 Jan 20, 2023: Healthcare Workers File Petition Asking FDA to Recall Fresenius Dialysis Machines to Protect Patients
7.35 Jan 09, 2023: Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance
7.36 Jan 09, 2023: Satellite Healthcare Appoints Board of Directors Chair and Vice Chair
7.37 Dec 13, 2022: Rockwell Medical Begins Selling its Hemodialysis Concentrates Products to New Clinics in Minnesota with its Largest Customer
7.38 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
7.39 Nov 23, 2022: Medtronic Reports Quarterly Earnings
7.40 Nov 22, 2022: Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
7.41 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
7.42 Nov 22, 2022: Fresenius Places Bonds With a Volume of EUR1 Billion
7.43 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
7.44 Nov 14, 2022: Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results
7.45 Nov 10, 2022: Study examines symptom burden before and after starting dialysis in older adults
7.46 Nov 09, 2022: Redsense Medical Interim Report Q3 - July - September, 2022
7.47 Nov 09, 2022: Redsense Medical Announces Interim Report Q3 – July – September, 2022
7.48 Nov 09, 2022: Asahi Kasei announces Consolidated Results for 1st and 2nd Quarter Fiscal 2022
7.49 Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022
7.50 Nov 04, 2022: Poly Medicure Announces Unaudited Standalone & Consolidated Financial Results for the Quarter Ended 0n 30th Sep. 2022
7.51 Nov 02, 2022: Nephros Announces Results for Quarter Ended September 30, 2022
7.52 Oct 31, 2022: Renalytix Reports Full Year Fiscal 2022 Results
7.53 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook
7.54 Oct 27, 2022: Satellite Healthcare introduces an innovative care model for people newly diagnosed with kidney disease requiring dialysis
7.55 Oct 26, 2022: Outset Medical to Report Third Quarter 2022 Financial Results Tuesday, November 8, 2022
7.56 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
7.57 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
7.58 Oct 12, 2022: Nephros to Present at LD Micro Main Event XV
7.59 Sep 29, 2022: UMC Health System and Dialyze direct collaborate to bring onsite dialysis options to Lubbock County and West Texas
7.60 Sep 26, 2022: Satellite Healthcare joins other non-profit partners to open first dialysis center in Hawai‘i focused on higher-risk patients
7.61 Sep 26, 2022: Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
7.62 Sep 20, 2022: Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum
7.63 Sep 15, 2022: New article brings forward support for home dialysis in connection with comorbidities
7.64 Sep 07, 2022: Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors
7.65 Sep 07, 2022: Medtronic to appear at September investor conferences
7.66 Aug 30, 2022: Outset Medical to Present at the 20th Annual Morgan Stanley Global Healthcare Conference
7.67 Aug 25, 2022: Somatus Names New Medical Executive to Direct the Delivery of World-Class Kidney Care
7.68 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
7.69 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
7.70 Aug 17, 2022: Mr. Rom Mendel appointed new CEO of Optinova
7.71 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
7.72 Aug 15, 2022: Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update
7.73 Aug 11, 2022: NanoVibronix announce quarter ended June 30, 2022
7.74 Aug 10, 2022: Nephros Announces Results for Quarter Ended June 30, 2022
7.75 Aug 05, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended June 2022
7.76 Aug 04, 2022: Poly Medicure announces Financial results For The Quarter Ended 30Th June 2022
7.77 Aug 01, 2022: Outset Medical Reports Second Quarter 2022 Financial Results and Provides 2022 Guidance
7.78 Aug 01, 2022: Outset Medical Resumes Shipment of Tablo Systems for Home Use Reports Second Quarter 2022 Financial Results and Provides 2022 Guidance
7.79 Aug 01, 2022: Miromatrix to Report Second Quarter 2022 Financial Results
7.80 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
7.81 Jul 27, 2022: Nephros Second Quarter 2022 Financial Results Conference Call
7.82 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Renal Dialysis Equipment - Pipeline Products by Stage of Development
Table 2: Renal Dialysis Equipment - Pipeline Products by Segment
Table 3: Renal Dialysis Equipment - Pipeline Products by Territory
Table 4: Renal Dialysis Equipment - Pipeline Products by Regulatory Path
Table 5: Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date
Table 6: Renal Dialysis Equipment - Ongoing Clinical Trials
Table 7: Renal Dialysis Equipment Companies - Pipeline Products by Stage of Development
Table 8: Renal Dialysis Equipment – Companies Pipeline Products by Stage of Development
Table 9: Access Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Dialysis Catheter - Product Status
Table 11: Dialysis Catheter - Product Description
Table 12: Dialysis Port - Product Status
Table 13: Dialysis Port - Product Description
Table 14: Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 15: AV Scoring Balloon - Product Status
Table 16: AV Scoring Balloon - Product Description
Table 17: Advanced Dialysis Methods Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Vibro-Care - Product Status
Table 19: Vibro-Care - Product Description
Table 20: Advent Access Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 21: av-Guardian - Product Status
Table 22: av-Guardian - Product Description
Table 23: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Acuswift - Product Status
Table 25: Acuswift - Product Description
Table 26: Next Generation Dialysis Device - Product Status
Table 27: Next Generation Dialysis Device - Product Description
Table 28: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: 5-FU Anti-Infective HemoStream Dialysis Catheter - Product Status
Table 30: 5-FU Anti-Infective HemoStream Dialysis Catheter - Product Description
Table 31: Aperture Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Vascular Access Device - Hemodialysis - Product Status
Table 33: Vascular Access Device - Hemodialysis - Product Description
Table 34: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Drug Eluting Tunneled Dialysis Catheter - Product Status
Table 36: Drug Eluting Tunneled Dialysis Catheter - Product Description
Table 37: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: MaxFlow - Product Status
Table 39: MaxFlow - Product Description
Table 40: SureFlow - Product Status
Table 41: SureFlow - Product Description
Table 42: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: CWP 800 Mini - Product Status
Table 44: CWP 800 Mini - Product Description
Table 45: Non PVC CAPD - Product Status
Table 46: Non PVC CAPD - Product Description
Table 47: oXiris - Product Status
Table 48: oXiris - Product Description
Table 49: Point of Care Generation 1 System - Product Status
Table 50: Point of Care Generation 1 System - Product Description
Table 51: Point of Care Generation 2 System - Product Status
Table 52: Point of Care Generation 2 System - Product Description
Table 53: PrisMax 2 System - Product Status
Table 54: PrisMax 2 System - Product Description
Table 55: Baxter International Inc - Ongoing Clinical Trials Overview
Table 56: oXiris - A Pilot Multicentre Open-Label Randomized Controlled Trial During Treatment for Acute Kidney Injury in Critically Ill Patients with Septic Shock Comparing Two Haemofilter Membrane Devices, The An69st and the Newly Available Oxiris Haemofiltration Membrane for Early Resolution of Shock As Well As Other Clinical and Technical Performance Outcomes
Table 57: oXiris - A Randomized, Controlled Trial to Evaluate Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) in Comparison with a Semi Selective Semipermeable Membrane (Standard AN-69) in COVID-19 Associated Acute Kidney Injury: oXAKI-COV Study
Table 58: oXiris - Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy with a High Adsorption Membrane (oXiris)
Table 59: oXiris - Clinical Study of Microcirculatory Parameters in Septic/Septic Shock Patients Treated with Oxiris Filter
Table 60: oXiris - Effect of Oxiris Membrane on Microcirculation Following Cardiac Surgery Under Cardiopulmonary Bypass: A Pilot Prospective Monocentric Study (Oxicard Study)
Table 61: oXiris - Effects of Removal of Endotoxin, Cytokines, and Uremic Toxins Using Blood Purification on Patients with Severe Septic Shock
Table 62: oXiris - Endotoxins and Cytokines Removal During Continuous Hemofiltration with oXiris
Table 63: oXiris - Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated with Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX
Table 64: oXiris - Real-time Monitoring of Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy: Propensity Score-matched Comparison Between oXiris and Polysulfone Membranes
Table 65: oXiris - Renal Replacement Therapy with a Cytokine Absorption Filter (oXiris) in Patients with Septic Shock: a Case-control Study Nested in a Cohort
Table 66: oXiris - The Effect of a Hemoperfusion with Polyethyleneimine-coated Membrane Filter (Oxiris) in Patients with Septic Shock: A Multicenter Randomized Controlled Trial
Table 67: oXiris - The Effects of Extracorporeal Blood Purification (oXiris) in Patients with Cardiogenic Shock Requiring VA-ECMO: A Prospective, Open-label, Randomized Controlled Pilot Study
Table 68: oXiris - The Effects of oXiris on Systemic Inflammation, Endothelial Dysfunction and Volume Control in Cardiac Surgery Patients Undergoing Cardiopulmonary Bypass
Table 69: oXiris - The Efficacy of Different Mode of Blood Purification in Septic Children
Table 70: Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 71: NuSpun Vascular Graft - Product Status
Table 72: NuSpun Vascular Graft - Product Description
Table 73: Bioteque Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Fold-Proof Dialysis Catheter - Product Status
Table 75: Fold-Proof Dialysis Catheter - Product Description
Table 76: BOA Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 7

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings